The World Health Organization, the Foundation for Innovative New Diagnostics and other partners on January 8 called for expressions of interest in Round 6 of the WHO Malaria Rapid Diagnostic Test Product Testing Programme.
The testing will look at the comparative performance of an antigen-detecting malaria rapid diagnostic test that is already available on the market. The WHO test will be based on testing against a range of cyro-preserved malaria parasite samples derived from an international malaria specimen bank. The testing will be undertaken at the U.S. Centers for Disease Control and Prevention’s Division of Parasitic Disease’s Malaria Branch.
Since 2008, the WHO and its partners have completed five rounds of testing. The tests add to the understanding of the possible performance of malaria rapid diagnostic tests to improve comprehensive testing recommendations in national malaria control programs performed by a range of organizations. Results from the most recent round, Round 5, are expected to be released and published this April.
The WHO and its partners ask that all interested parties submit expressions of interest to the WHO by February 7. Round 6 of the Malaria Rapid Diagnostic Test Product Testing Programme is set to begin in May.
The testing will look at the comparative performance of an antigen-detecting malaria rapid diagnostic test that is already available on the market. The WHO test will be based on testing against a range of cyro-preserved malaria parasite samples derived from an international malaria specimen bank. The testing will be undertaken at the U.S. Centers for Disease Control and Prevention’s Division of Parasitic Disease’s Malaria Branch.
Since 2008, the WHO and its partners have completed five rounds of testing. The tests add to the understanding of the possible performance of malaria rapid diagnostic tests to improve comprehensive testing recommendations in national malaria control programs performed by a range of organizations. Results from the most recent round, Round 5, are expected to be released and published this April.
The WHO and its partners ask that all interested parties submit expressions of interest to the WHO by February 7. Round 6 of the Malaria Rapid Diagnostic Test Product Testing Programme is set to begin in May.